Data / Form D filings / Centerline Biomedical, Inc.
Centerline Biomedical, Inc.: Form D filings
Centerline Biomedical, Inc., a biotechnology company in Warrensville Heights, OH, filed 4 Form D notices with the SEC between 2023 and 2025. The latest, on April 25, 2025, reports $10.8 million sold of a $15 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4535 Renaissance Parkway, Warrensville Heights, OH, 44128
- Phone
- (216) 445-0830
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1998847
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 25, 2025 | New notice | $15,000,000 | $10,784,000 | $4,216,000 | 8 | Apr 11, 2025 | sec.gov |
| Nov 3, 2023 | New notice | $34,675,000 | $34,675,000 | 22 | Feb 4, 2022 | sec.gov | |
| Nov 3, 2023 | New notice | $12,705,496 | $12,705,496 | 106 | Aug 16, 2019 | sec.gov | |
| Nov 3, 2023 | New notice | $13,650,000 | $13,650,000 | 65 | Aug 15, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael Whitman | Director | |
| Todd Schwarzinger | Director | |
| Mitch Wolf | Director | |
| Gulam Khan | Executive Officer, Director | |
| Arnaud Marie | Director | |
| Indrani Egleston | Executive Officer |
Other biotechnology companies in Ohio that filed recently
- LAACClamp Inc. $900,000 · Oct 5, 2026
- Autology, Inc. $3.4 million · Sep 30, 2026
Every Form D from the week of Apr 21, 2025 · All recent filings in Ohio · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Centerline Biomedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.